SCHEMBL23844132

SCHEMBL23844132

CO[C@](CF)(CO[PH](=O)N[C@@H](C)C(=O)OC1CCOCC1)[C@H](Cc1ccc2c(N)ncnn12)OC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23844091 0.90 — —
SCHEMBL23819057 0.79 RIPK1 (0.30) —
SCHEMBL23844006 0.76 — —
SCHEMBL27437352 0.72 POLRMT (0.31) —
SCHEMBL27440177 0.71 CYP3A4 (0.33) —
SCHEMBL23844093 0.70 RIPK1 (0.30) —
SCHEMBL27439514 0.69 RIPK1 (0.31) —
SCHEMBL23819047 0.68 — —
SCHEMBL23844242 0.68 RIPK1 (0.33) —
SCHEMBL26333188 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292348-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-23 — — US disclosed
Send feedback